SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-09-002845
Filing Date
2009-04-15
Accepted
2009-04-15 09:26:51
Documents
2
Period of Report
2009-04-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ALSERES PHARMACEUTICALS, INC. b75024ape8vk.htm 8-K 12367
2 EX-99.1 - PRESS RELEASE DATED APRIL 14, 2009 b75024apexv99w1.htm EX-99.1 6416
  Complete submission text file 0000950135-09-002845.txt   20664
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-06533 | Film No.: 09749913
SIC: 2834 Pharmaceutical Preparations